|
 MRNA
vaccines, like that developed jointly by BionTech and Pfizer, prompt
the human body to make a protein that is part of the virus,
triggering an immune response.
"A vaccine manufacturer in Vietnam has already expressed its
interest to become a mRNA-based COVID-19 vaccine technology transfer
hub," Kidong Park, the WHO representative in Vietnam, said in an
emailed statement to Reuters.
The proposal was being reviewed by the WHO, said Park, who added
that the organisation expects Vietnam to also apply for "large scale
manufacturing" of an mRNA-based COVID-19 vaccine.
Park did not say which vaccine manufacturer had expressed interest
in the plans.
[to top of second column] |
On Tuesday, Vietnamese state media said the country was seeking the
transfer of the technology to domestically manufacture COVID-19
vaccines, as officials warned of supply issues until the end of the
year.
The WHO in April said it was seeking to expand the capacity of low
and middle-income countries to produce and scale up the
manufacturing of vaccines to help bring the pandemic under control.
"If Vietnam will host a mRNA-based COVID-19 vaccine technology
transfer hub, it will contribute to mRNA-based COVID-19 vaccine
production in Vietnam as well as in the region," Park told Reuters.
(Reporting by James Pearson; Editing by Martin Petty)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
